Semaglutide Cuts MACE in People With Overweight, Obesity, Regardless of HbA1c
Reduction seen in cardiovascular events irrespective of baseline HbA1c or change in HbA1c
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.